• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • BioAsia 2023 to be held in February 24-26 in Telangana, India
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian?
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE
  • Event: Australia’s biggest week in biotech kicks off in Perth
  • $3 trillion growth reported for biotech sector in USA
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect”
  • Vaccination, Rising Deaths, And The False Narrative
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    July 26, 2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Articles»Race against COVID19 treatment

Race against COVID19 treatment

0
By Biotech Express on April 19, 2020 Articles, SARS- CoV2 & COVID-19 Updates

by Biotech Express Bureau | Updated on April 20, 2020

There is no cure (or vaccine) against COVID19; Doctors can only relieve the symptoms. Since it is a new pathogen the chances of making a candidate vaccine very soon are very low, yet world’s scientists are working rigorously to find one. The biotech industry, both by pharmaceutical companies and research organisations across the world are working on the development of novel coronavirus vaccines and possible treatment.
But to kill the virus a chemical or biological entity is required which takes time for discovery, approval and gain trust.

The most effective agent for any viral disease is vaccine. Vaccine attenuates the virus and also helps our immune system to destroy and recognize the virus by making antibodies.

According to a post update of Livemint.com on 16th April, nearly 70 ‘vaccine candidates’ are being tested and at least three have moved to the human clinical trial stage, but a vaccine for the novel coronavirus is unlikely to be ready for mass use before 2021.

The pioneer research from India seeking for vaccine candidate came after Scientists, led by Shailendra K. Saxena, sequenced the genes that encode the spike (S) proteins in the outer layer of two strains of coronaviruses isolated from the seafood market of Wuhan, where the novel virus first emerged. They then compared the S protein-coding genes of the novel coronaviruses with those of different strains of SARS-CoV that usually infects bats. The study was published online on 28 March 2020 in Nature.

In a statement of 27th March, the Indian Council for Medical Research said on Friday that India is likely to participate in the solidarity trial of coronavirus vaccine to be conducted by the World Health Organization. “We are likely to start our participation soon in solidarity trial that the World Health Organization is starting.
Earlier we did not do it because our numbers were so small that our contribution would have looked minuscule. The ICMR has asked the Department of Biotechnology (DBT) to undertake vaccine development programme.
On 9th April, two candidate vaccines for COVID-19 have entered the first phase of human clinical trials and another 60 candidate vaccines were in pre-clinical studies, the World Health Organisation (WHO) confirmed.

Vaccine Candidates
The most recent vaccine candidate jointly developed by CanSino Biological Inc and Beijing Institute of Biotechnology uses the non-replicating viral vector as the platform, same as the non-corona candidates like Ebola, to develop a vaccine with a ‘Adenovirus Type 5’ candidate.

US drugmaker Gilead is racing against time with its anti-viral drug Remdesivir. This anti-viral drug is undergoing large trials in China and could be a front runner in coronavirus treatments. According to the company, the drug showed good results in animal testing against MERS and SARS, both of which are also types of coronaviruses. This experimental drug was also been tested against Ebola, however, despite success in animal testing, the drug did not fare too well in humans. The drug is yet not approved to treat any disease, but the company is hoping it could be an effective treatment against Coronavirus.

Another US biopharma company Altimmune is working on an intranasal coronavirus vaccine, which is being developed based on a vaccine technology platform similar to NasoVAX, the influenza vaccine developed by Altimmune. Animal testing will begin shortly.

mRNA-1273 vaccine by Moderna and Vaccine Research Center entered in phase one clinical trials in April.
China’s National Medical Products Administration has approved Favilavir, an anti-viral drug as a treatment against coronavirus. The drug is being touted as the first approved coronavirus drug. While clinical trials are still ongoing in Shenzhen, Guangdong province, results of clinical trials involving 70 patients reportedly showed treatment efficacy with very little side effects.

Korean drugmaker Ilyang Pharma has claimed that its Leukemia drug Supect is found effective against coronavirus. However, it is still to be approved by drug authorities in the country.

Indian drug regulator has approved “restricted use” of combination Liponavir and Ritonavir. This was used by doctors in Sawai Man Singh (SMS) Hospital who claim to have successfully cured Italian COVID-19 patients using a combination of these drugs with swine flu and malaria drugs. Experts said a lot more clinical trials are needed to establish replicability of this treatment.Some Indian firms taking the lead are Serum Institute of India and Zydus Cadila who have disclosed their candidates for coronavirus vaccine.

In India Adar C. Poonawalla, CEO of Pune-based Serum Institute of India(SII), the world’s largest vaccine manufacturer, announced that SII has collaborated with two American companies to develop a Make in India Covid-19 vaccine.

More recently, plasma therapy has been used in the treatment of diseases like SARS in 2003, which was also caused by a coronavirus, as well as MERS in 2012.The therapy is the Convalescent Plasma Therapy. Chances of treating coronavirus patients with plasma therapy are looking up, with the Indian Council of Medical Research (ICMR) hoping to begin clinical trials within the next two weeks. Several states, including Kerala, Maharashtra, Tamil Nadu and Delhi have sought permission from the Centre to conduct plasma therapy to treat coronavirus patients.

An international effort, ‘The coalition of Epidemic Preparedness Innovations’ (CEPI), a global collaboration between public, private, philanthropic, and civil society organisations to develop vaccines for infectious disease epidemics, is currently supporting developmental work on four vaccine candidates.Research organisations such as the National Institutes of Health (NIH), US and Indian Council of Medical Research are also developing a vaccine for the coronavirus.

References:
1. https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf
2.https://indiabioscience.org/columns/general-science/covid-19-vaccine-development-and-therapeutic-strategies
3.https://www.statnews.com/2020/04/16/early-peek-at-data-on-gilead-coronavirus-drug-suggests-patients-are-responding-to-treatment/
4.https://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/
5.Study uncovers routes to vaccine for novel Coronavirus doi:10.1038/nindia.2020.52 Published online 28 March 2020
6.https://www.livemint.com/news/india/covid-19-six-indian-companies-working-on-coronavirus-vaccine-11587016987400.html

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian?

Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE

Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect”

Leave A Reply Cancel Reply

Current Issue – October 2022
Upcoming Event

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • BioAsia 2023 to be held in February 24-26 in Telangana, India January 10, 2023
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt November 10, 2022
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian? November 1, 2022
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE October 31, 2022
  • Event: Australia’s biggest week in biotech kicks off in Perth October 26, 2022
  • $3 trillion growth reported for biotech sector in USA October 25, 2022
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect” September 21, 2022
  • Vaccination, Rising Deaths, And The False Narrative September 20, 2022
  • Guestorial: Genome Mapping Techniques and its Application in Aquaculture September 19, 2022
  • Bombay HC Issues Notice To Bill Gates, Serum Institute, DGCI, Others Over Plea On Alleged ‘Vaccine Death’ September 5, 2022
  • Deaths due Covid-19 vaccines should be compensated by vaccine makers: Expert hope on Kerala HC remark August 21, 2022
  • Maker of Dolo-650, pandemic’s ‘magic pill’, faces income tax searches and PIL petitions August 20, 2022
  • Anthony Fauci, Controversial US Top-doc FINALLY, To Retire By Year-end August 20, 2022
  • SII’s Cervevac: The new DCGI approved vaccine without published clinical trial results August 20, 2022
  • Pitch your Start-up to National/International Venture Capitalists – first ever opportunity provided to Bio-Start-ups by FABA August 19, 2022
  • India’s Clinical Trial Registry might disappear soon and so the history of pharma record August 19, 2022
  • Nearly Half of Pregnant Women in Pfizer Trial Miscarried August 10, 2022
  • Researchers develop Cellulose shoes made by bacteria August 9, 2022
  • Biocon Sdn. Bhd. Enters Malaysia Book of Records as the First & the Largest Integrated Insulin Manufacturing Facility August 5, 2022
  • CBI Arrests of CDSCO officials, a Biocon official & Intermediaries in an alleged bribery case exposed Corruption in Govt and Pharma sector July 27, 2022
  • We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO July 26, 2022
  • EVENT HIGHLIGHTS: Genome editing as a novel technology for sustainable development July 24, 2022
  • US Military Doctor Testifies under Oath That She Was ORDERED To ‘Cover up’ COVID Vaccine Injuries July 24, 2022
  • Climatic Effect on Marine Biodiversity and their impact on coral reefs July 23, 2022
  • Highlights of India’s first Biotech startup Expo June 13, 2022
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity June 6, 2022
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds May 30, 2022
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft May 26, 2022
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak May 25, 2022
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid May 25, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.